Log In
Print
BCIQ
Print
Print this Print this
 

naloxone (E-1415)

  Manage Alerts
Collapse Summary General Information
Company Elorac Inc.
DescriptionOpiate antagonist
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationItch
Indication DetailsTopical treatment of pruritus accompanying cutaneous T cell lymphoma (CTCL)
Regulatory Designation

U.S. - Orphan Drug (Topical treatment of pruritus accompanying cutaneous T cell lymphoma (CTCL))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today